Jiayi Huang

4PUBLICATIONS
2CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 05, 2026
Inetetamab-Based Regimens for Patients with HER2-Positive Metastatic Breast Cancer: A Real-World Retrospective Study.

Liping Chen, Jiayi Huang, Xuelian Chen

|Dec 02, 2025
Delayed Cardiac Dysfunction During Prolonged Use of Trastuzumab for the Treatment of HER2-Positive Metastatic Breast Cancer.

Xuelian Chen, Xiaofeng Lan, Li Xiao

|Jul 03, 2025
Continuous Anlotinib Combined with Oral Vinorelbine has Shown Anti-Tumor Efficiency in Refractory HER2 Negative Advanced Breast Cancer.

Jia-Yi Huang, Yan Zhang, Cai-Wen Du

|Apr 25, 2024
The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer.

Jia-Yi Huang, Xue-Lian Chen, Xiao-Feng Xie

Pageof 1

Frequent Collaborators

1 joint publications

Xiao Chen

1 joint publications

Cai-Wen Du